In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Dianthus Therapeutics (DNTH – Research Report), ...
Dianthus Therapeutics, Inc. NEW YORK and WALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing ...
Zacks.com on MSN2d
Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?Jazz (JAZZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
Dyne Therapeutics Inc.-5.60% $1.56B ...
After hours: 11 February at 4:00:09 pm GMT-5 ...
Pre-market: 4:00:28 am GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback